A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection

Overview of attention for article published in Journal of Hepatology, July 2014

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 4 news outlets
patent: 5 patents

f1000: 1 research highlight platform

Readers on

mendeley: 87 Mendeley

So far, Altmetric has seen 5 patents that reference this research output.

USE OF IFN-LAMBDA MRNA FOR TREATING VIRAL INFECTIONS

Application EP-4553084-A2

European Patent Office

14 May 2025

Medical use of interferon-lambda for the treatment of fibrosis

Grant US-11975046-B2

United States of America

07 May 2024

USE OF IFN-LAMBDA MRNA FOR TREATING VIRAL INFECTIONS

Application WO-2022096582-A1

World Intellectual Property Organisation (WIPO)

12 May 2022

PEGYLATED INTERFERON LAMBDA FOR ORAL ADMINISTRATION, AND METHOD FOR PRODUCING SAME

Application WO-2019050437-A1

World Intellectual Property Organisation (WIPO)

14 Mar 2019

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 1 additional patents.